12 to 20 Plus Welcomes New Chief Operations Officer (COO) to Its Management Team and Moves Corporate Headquarters

SAN LUIS OBISPO, CA, Apr. 13, 2004 (MARKET WIRE via COMTEX) -- 12 to 20 Plus, Inc. (TTTP) is pleased to announce Michael Smith has joined the company as its Chief Operations Officer (COO). "Smith's varied corporate background and senior management experience in E-Commerce, Business Integration and expertise in regards to regulatory compliance issues with Sarbanes-Oxley, Patriot and Patriot II compliance is a perfect fit for our future plans," said Carol Slavin, President.

Some highlights of his past achievements are:

-- Designed and implemented Internet banking, trading and financial
services prototypes and production system for Zions Bancorporation and
Nevada State Bank.
-- Led initiative which resulted in the award to Zions Bancorporation of
the Utah Digital Signature Act contract with Novell, Bankers Trust
(CertCo), Digital Signature Trust Company and OmniMark. This was the first
such contract and licensing in the world and the winning proposal was used
as a "template" for other states and countries.
-- Founded E-SOL International to provide Enterprise Services OnLine
within a framework that included: an "Enterprise Relationship Management
Gateway"; a managed Public Key Cryptography Infrastructure (PKI); a
Business Pattern Processing service; Current focus on regulatory compliance
issues with Sarbanes-Oxley, Patriot and Patriot II compliance.
-- Participated as member of the senior administrative team for
California Institute of Integral Studies in planning, budgeting, and the
accreditation process (WASC). As Comptroller and Director of Business
Services and Director of Information Systems and Technology and managed the
following departments: Accounting, Payroll, Facilities, Book Store,
Purchasing, and Information Systems and Technology.

"The Company has also moved into its new Corporate Headquarters," Ms. Slavin announced. "This new facility will allow us to expand our corporate infrastructure as necessary. We felt the need to make the move now in anticipation of significant growth through emerging marketing strategies and our ongoing desire to grow our company through acquisitions."

About 12 to 20 Plus, Incorporated

12 to 20 Plus, Incorporated is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional formulas and nutraceuticals. One of the company's flagship products, Zit Stick(R), is part of a "spa style" acne therapy system(TM). The market for acne remedies is expected to reach $370 million in 2004. 12 to 20 Plus, Inc. also markets highly effective condition-specific dietary supplements containing the most sophisticated combination of extensively researched nutritional elements available. The products are manufactured by FDA-approved labs and do not contain herbs. Instead, the company utilizes potent pharmaceutical grade "amino acids," important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. Some of (NRG) products include Anaplex(TM), the antidepressant drug alternative; VisionKare(TM), an advanced supplement for macular degeneration; ChemoKare(TM), a unique combination of extracts designed to treat the side effects of chemotherapy; QuitSystem(R), a neuronutrient supplementation for recovery from alcohol, drugs and smoking and Hinoki Bana(TM), a treatment for men and women with hair loss problems. Retail sales in the explosive dietary supplement market are expected to hit $21 billion by year 2007, according to Frost & Sullivan reports. www.12to20plus.com

This release contains forward looking statements and projections. Such statements and projections are made under the safe harbor provisions of applicable laws and regulations. Any reader should be advised that factors such as development of new capital funding, competition, lack of expert personnel and other factors may materially affect in an adverse manner actual results of operations. Further, any reader of this release should seek competent advice from a registered broker or financial planner prior to investing in shares of the issuer.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.